Objection pursuant to Rule 112: Extension of the approval periods of the active substances amidosulfuron, beta cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (D062951)

Date: 10.10.2019 · Reference: B9-0104/2019

Overall Result: 417 For
417 For
200 Against
40 Abstention
92 Did not vote
Filter by Country
← Go back